FI950010L - Bradykiniiniantagonistien käyttö lääkeaineiden valmistamiseksi virussairauksien hoitamiseksi - Google Patents

Bradykiniiniantagonistien käyttö lääkeaineiden valmistamiseksi virussairauksien hoitamiseksi Download PDF

Info

Publication number
FI950010L
FI950010L FI950010A FI950010A FI950010L FI 950010 L FI950010 L FI 950010L FI 950010 A FI950010 A FI 950010A FI 950010 A FI950010 A FI 950010A FI 950010 L FI950010 L FI 950010L
Authority
FI
Finland
Prior art keywords
medicaments
preparation
treatment
viral diseases
bradykinin antagonists
Prior art date
Application number
FI950010A
Other languages
English (en)
Swedish (sv)
Other versions
FI950010A0 (fi
FI117320B (fi
Inventor
Klaus Wirth
Irvin Winkler
Fred Lembeck
Gerhard Breipohl
Stephan Henke
Jochen Knolle
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI950010A0 publication Critical patent/FI950010A0/fi
Publication of FI950010L publication Critical patent/FI950010L/fi
Application granted granted Critical
Publication of FI117320B publication Critical patent/FI117320B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/043—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/18—Kallidins; Bradykinins; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI950010A 1993-12-31 1995-01-02 Bradykiniiniantagonistien käyttö lääkeaineiden valmistamiseksi virussairauksien hoitamiseksi FI117320B (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4345062A DE4345062A1 (de) 1993-12-31 1993-12-31 Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von Viruserkrankungen

Publications (3)

Publication Number Publication Date
FI950010A0 FI950010A0 (fi) 1995-01-02
FI950010L true FI950010L (fi) 1995-07-01
FI117320B FI117320B (fi) 2006-09-15

Family

ID=6506576

Family Applications (1)

Application Number Title Priority Date Filing Date
FI950010A FI117320B (fi) 1993-12-31 1995-01-02 Bradykiniiniantagonistien käyttö lääkeaineiden valmistamiseksi virussairauksien hoitamiseksi

Country Status (21)

Country Link
US (1) US5789383A (fi)
EP (1) EP0661058B1 (fi)
JP (1) JP3828593B2 (fi)
KR (1) KR100358822B1 (fi)
CN (1) CN1119171C (fi)
AT (1) ATE255417T1 (fi)
AU (1) AU696629B2 (fi)
BR (1) BR9405308A (fi)
CA (1) CA2138933C (fi)
DE (2) DE4345062A1 (fi)
DK (1) DK0661058T3 (fi)
ES (1) ES2211874T3 (fi)
FI (1) FI117320B (fi)
HU (1) HU226374B1 (fi)
IL (1) IL112183A (fi)
MY (1) MY112888A (fi)
NO (1) NO317660B1 (fi)
PT (1) PT661058E (fi)
RU (1) RU2228195C2 (fi)
UA (1) UA41326C2 (fi)
ZA (1) ZA9410381B (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2737408B1 (fr) 1995-07-31 1997-09-05 Oreal Utilisation d'un antagoniste de bradykinine dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
DE19612067A1 (de) * 1996-03-27 1997-10-02 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von chronisch fibrogenetischen Lebererkrankungen und akuten Lebererkrankungen
WO2016170382A1 (en) * 2015-04-23 2016-10-27 INSERM (Institut National de la Santé et de la Recherche Médicale) Pharmaceutical compositions comprising a bradykinin 2 receptor antagonist for prevention or treatment of impaired skin wound healing
EP4067368A1 (en) 2016-06-01 2022-10-05 Athira Pharma, Inc. Compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE63490B1 (en) * 1988-11-24 1995-05-03 Hoechst Ag Peptides having bradykinin antagonist action
MX9100717A (es) * 1990-08-24 1992-04-01 Syntex Inc Antagonistas de la bradiquinina
DK31991D0 (da) * 1991-02-25 1991-02-25 Carlbiotech Ltd As Peptid og farmaceutisk praeparat indeholdende et saadant peptid
AU660683B2 (en) * 1991-04-01 1995-07-06 Cortech, Inc. Bradykinin antagonists
EP0618810B1 (en) * 1991-04-19 2001-07-04 Scios Nova Inc. Bradykinin antagonist peptides
JP3465000B2 (ja) * 1991-04-19 2003-11-10 シオス・ノヴァ・インコーポレイティット ブラジキニン型ペプチド
US5240694A (en) * 1991-09-23 1993-08-31 University Of Virginia Combined antiviral and antimediator treatment of common colds
RU2043115C1 (ru) * 1992-06-11 1995-09-10 Товарищество с ограниченной ответственностью "Резонанс-фарма" Средство, повышающее выживаемость и облегчающее течение вирусной инфекции - экстромелии в эксперименте
AU680870B2 (en) * 1993-04-28 1997-08-14 Astellas Pharma Inc. New heterocyclic compounds
WO1996006083A1 (en) * 1994-08-24 1996-02-29 Pfizer Pharmaceuticals Inc. 2-(piperazinyl-1-carbonylmethyl)-1,4-dihydropyridines as bradykinin antagonists

Also Published As

Publication number Publication date
EP0661058B1 (de) 2003-12-03
US5789383A (en) 1998-08-04
KR100358822B1 (ko) 2003-01-24
HUT71422A (en) 1995-11-28
ES2211874T3 (es) 2004-07-16
ATE255417T1 (de) 2003-12-15
NO945094D0 (no) 1994-12-30
RU94045140A (ru) 1996-10-20
NO945094L (no) 1995-07-03
CN1119171C (zh) 2003-08-27
CA2138933C (en) 2010-02-23
JP3828593B2 (ja) 2006-10-04
JPH07206703A (ja) 1995-08-08
UA41326C2 (uk) 2001-09-17
NO317660B1 (no) 2004-11-29
MY112888A (en) 2001-10-31
DE59410340D1 (de) 2004-01-15
AU696629B2 (en) 1998-09-17
CN1108138A (zh) 1995-09-13
DK0661058T3 (da) 2004-04-05
HU9403783D0 (en) 1995-02-28
FI950010A0 (fi) 1995-01-02
IL112183A (en) 2001-01-11
DE4345062A1 (de) 1995-07-13
HU226374B1 (en) 2008-10-28
FI117320B (fi) 2006-09-15
KR950016779A (ko) 1995-07-20
AU8179194A (en) 1995-07-13
PT661058E (pt) 2004-04-30
EP0661058A1 (de) 1995-07-05
IL112183A0 (en) 1995-03-15
ZA9410381B (en) 1995-08-29
RU2228195C2 (ru) 2004-05-10
BR9405308A (pt) 1995-09-19
CA2138933A1 (en) 1995-07-01

Similar Documents

Publication Publication Date Title
FI956014L (fi) Nona- ja dekapeptidien käyttö lääkkeen valmistamiseksi AIDS-sairauden hoitoon
NO904694L (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater.
NO901684L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater.
FI990268A0 (fi) Ei-peptidi-NK-antagonistin käyttö ihosairauksien ja kutinan hoitoon tarkoitettujen lääkkeiden valmistukseen
NO914036L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater
AU4048295A (en) Peptide medicaments for the treatment of disease
NO903088D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive diazepin-derivater.
NO904986D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepin-derivater.
FI910413A7 (fi) Tooppiset valmisteet ihmisen kynsien hoitamiseksi
NO902411D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-n-propylaminer.
DK19893A (da) Praeparat til nasal behandling
ZA983602B (en) Use of tetrahydropyridine derivatives for the preparation of drugs for the treatment of diseases which cause demyelination
DE69420229D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
AU9173191A (en) Medicaments for the treatment of papillomavirus diseases
AU3684395A (en) Use of camptothecin or derivatives thereof for the manufacture of a medicament for the treatment of viral diseases
NO914071D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser
NO991164D0 (no) Farmas°ytisk preparat for behandling av virussykdommer
FI950010L (fi) Bradykiniiniantagonistien käyttö lääkeaineiden valmistamiseksi virussairauksien hoitamiseksi
NO168477C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kondenserte diazepinoner.
NO900972D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater.
FI961494L (fi) Farmaseuttisia koostumuksia ja niiden käyttö, etenkin hermoston rappeutumissairauksien hoitamiseksi
NO903939L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kondenserte diazepinoner.
NO892871D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
ZA944671B (en) Medicaments for the treatment of inflammatory diseases
NO904470D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzodiazepinderivater.

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 117320

Country of ref document: FI

MA Patent expired